Skip to main content

Table 1 Comparison of the clinical efficacy [cases (%)]

From: Concurrent vs. sequential chemoradiotherapy: a survival boost for lung cancer patients

Groups

Complete relief

Partial relief

Disease stability

Disease progression

Remission rate

Control rate

The control group (n = 78)

26 (33.33)

32 (41.03)

12 (15.38)

8 (10.26)

58 (74.36)

70 (89.74)

The observation group (n = 80)

32 (40.00)

40 (50.00)

5 (6.25)

3 (3.75)

72 (90.00)

77 (96.25)

x2 value

    

6.626

3.927

P value

    

0.010

0.048